Comparing Effects of Liraglutide and Bariatric Surgery on Weight Loss, Liver Function, Body Composition, Insulin Resistance, Endothelial Function and Biomarkers of Non-alcoholic Steatohepatitis (NASH) in Obese Asian Adults (CGH-LiNASH)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT02654665

Recruitment Status : Unknown

Verified January 2018 by Joan Khoo Joo Ching, Changi General Hospital.
Recruitment status was: Recruiting

First Posted : January 13, 2016

Last Update Posted : January 30, 2018

Sponsor:

Information provided by (Responsible Party):

Joan Khoo Joo Ching, Changi General Hospital

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Unknown
Actual Primary Completion Date :	December 2017
Estimated Study Completion Date :	December 2018

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Khoo J, Hsiang JC, Taneja R, Koo SH, Soon GH, Kam CJ, Law NM, Ang TL. Randomized trial comparing effects of weight loss by liraglutide with lifestyle modification in non-alcoholic fatty liver disease. Liver Int. 2019 May;39(5):941-949. doi: 10.1111/liv.14065. Epub 2019 Feb 24.

To Top